COMPARATIVE REAL-WORLD EFFECTIVENESS OF BIOLOGIC THERAPIES FOR PREVENTING POSTOPERATIVE ENDOSCOPIC RECURRENCE OF CROHN'S DISEASE. (PubMed, Am J Gastroenterol) - Sep 19, 2026 - "In this real-world cohort, biologic prophylaxis is associated with reduced endoscopic recurrence in CD. Both ustekinumab and vedolizumab are effective options, including after prior TNF exposure."
Journal • Real-world evidence • Crohn's disease • Gastroenterology • Immunology • Inflammatory Bowel Disease
|
|
Anthony R MacLean; Ashley N Clarke; Cathy Lu; Christine Wang; Christopher Ma; Cynthia H Seow; Gilaad G Kaplan; Joëlle St-Pierre; Kerri L Novak; Mark S Silverberg; Mashal Fida; Newaz Shubidito Ahmed; Nima Hamidi; Paulo G Kotze; Rakhbeer Boparai; Remo Panaccione; William Donald Buie
|